These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 3447717)

  • 1. Identification and characterization of dopamine receptors in the cardiovascular system.
    Goldberg LI; Kohli JD
    Cardiologia; 1987 Dec; 32(12):1603-7. PubMed ID: 3447717
    [No Abstract]   [Full Text] [Related]  

  • 2. [Dopaminergic stimulation in cardiology: its current status and future strategies].
    Cherchi A; Mercuro G
    Cardiologia; 1987 Dec; 32(12):1631-9. PubMed ID: 3329022
    [No Abstract]   [Full Text] [Related]  

  • 3. Dopamine: pharmacologic and therapeutic aspects.
    Velasco M; Luchsinger A
    Am J Ther; 1998 Jan; 5(1):37-43. PubMed ID: 10099036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Dopaminergic receptors in the cardiovascular system: their biochemical characterization and pharmacological importance].
    Missale C; Liberini P; Lombardi C; De Cotiis R; Memo M; Spano PF
    Cardiologia; 1987 Dec; 32(12):1613-6. PubMed ID: 3329021
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical use of dopamine].
    Goldberg LI; Hsieh YY
    Internist (Berl); 1978 Jul; 19(7):427-30. PubMed ID: 357329
    [No Abstract]   [Full Text] [Related]  

  • 6. Long term administration of dopamine: is there a development of tolerance?
    Braun GG; Bahlmann F; Brandl M; Knoll R
    Prog Clin Biol Res; 1989; 308():1097-9. PubMed ID: 2550954
    [No Abstract]   [Full Text] [Related]  

  • 7. [Dopamine receptors in the cardiocirculatory system: an autoradiographic study].
    Amenta F; De Rossi M; Ricci A; Amenta D
    Cardiologia; 1987 Dec; 32(12):1609-12. PubMed ID: 3329020
    [No Abstract]   [Full Text] [Related]  

  • 8. [Peripheral dopamine DA1-type receptors: their localization, functional role and possible clinical implications].
    Mannelli M; Pupilli C; Baldi E; DeFeo ML
    Cardiologia; 1987 Dec; 32(12):1617-21. PubMed ID: 2965980
    [No Abstract]   [Full Text] [Related]  

  • 9. [Pharmacological explanation of dopamine (author's transl)].
    Shigiya R; Seta K; Arisaka M; Tsunoda K; Watabe M
    Kokyu To Junkan; 1973 Dec; 21(12):1113-6. PubMed ID: 4148952
    [No Abstract]   [Full Text] [Related]  

  • 10. Dopamine, cardiovascular dopamine receptors and chronic heart failure.
    Brodde OE
    Cardiologia; 1995 Dec; 40(12 Suppl 1):125-9. PubMed ID: 8903050
    [No Abstract]   [Full Text] [Related]  

  • 11. Cardiovascular and renal actions of dopamine: potential clinical applications.
    Goldberg LI
    Pharmacol Rev; 1972 Mar; 24(1):1-29. PubMed ID: 4554480
    [No Abstract]   [Full Text] [Related]  

  • 12. [Dopamine and the cardiovascular system].
    Jarecki M; Cybulska I
    Kardiol Pol; 1972; 15(2):241-7. PubMed ID: 4403277
    [No Abstract]   [Full Text] [Related]  

  • 13. The effects of some gastrointestinal hormones and metoclopramide on cardiovascular dopamine receptors [proceedings].
    Blower PR; Flack JD; Day MD
    Br J Pharmacol; 1977 Sep; 61(1):124P-125P. PubMed ID: 912177
    [No Abstract]   [Full Text] [Related]  

  • 14. Dopamine and dopamine receptors as target sites for cardiovascular drug action.
    Berkowitz BA
    Fed Proc; 1983 Oct; 42(13):3019-21. PubMed ID: 6137421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Problem of neuronal reception and the dopamine hypothesis of schizophrenia].
    Lideman RR; Zlobina GP; Mukhin AG
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1980; 80(5):762-9. PubMed ID: 6106337
    [No Abstract]   [Full Text] [Related]  

  • 16. The therapeutic potential of dopamine modulators on the cardiovascular and renal systems.
    Doggrell SA
    Expert Opin Investig Drugs; 2002 May; 11(5):631-44. PubMed ID: 11996645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The 3d catecholamine--dopamine].
    Sotskova TV
    Klin Med (Mosk); 1970 Apr; 48(4):117-20. PubMed ID: 4915309
    [No Abstract]   [Full Text] [Related]  

  • 18. [Cardiovascular pharmacology (IX). Angiotensin-converting enzyme inhibitors in hypertension and heart failure].
    de Teresa E; Espinosa JS; Gómez Doblas JJ
    Rev Esp Cardiol; 1995 Feb; 48(2):128-41. PubMed ID: 7886264
    [No Abstract]   [Full Text] [Related]  

  • 19. Cardiovascular dopamine receptors: recent advances in agonists and antagonists of the DA1-receptor.
    Berkowitz BA; Ohlstein EH
    J Cardiovasc Pharmacol; 1984; 6 Suppl 4():S559-63. PubMed ID: 6210423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of human neuroblastoma by dopamine antagonists.
    McGrath PC; Neifeld JP
    Surgery; 1985 Aug; 98(2):135-42. PubMed ID: 4023914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.